ArticleInternational urology and nephrology2026
Correlation between S.T.O.N.E score and channel size selection in percutaneous nephrolithotomy.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Renal Imaging Characteristics Predicting Percutaneous Access for Staghorn Stone Management.Current urology reports · 2026Review
- Comment on "Correlation between S.T.O.N.E score and channel size selection in percutaneous nephrolithotomy".International urology and nephrology · 2026Article
- Perspectives on the global burden of type 1 diabetes mellitus-related chronic kidney disease.International urology and nephrology · 2026Article
- Comment on "Analysis of acute glomerulonephritis disease burden and incidence trends in China, 1990-2021".International urology and nephrology · 2026Article
- Limitations of single-center retrospective studies in sepsis-associated AKI research: a call for broader, prospective approaches.International urology and nephrology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
objectiveTo evaluate the predictive value and influence of the S.T.O.N.E. nephrolithiasis scoring system on access tract size selection during percutaneous nephrolithotomy (PCNL).
methodsA retrospective analysis was performed on the clinical data of 323 patients who underwent PCNL. Preoperative stones were assessed using the S.T.O.N.E. score, which was categorized into a high-score group (9-13) and a low-score group (5-8). Postoperative complications were graded using the Clavien classification system and divided into a mild group (no or Grade I complications) and a severe group (Grade II or higher complications). Stratified univariate analysis was conducted to investigate the relationship between access tract size selection during PCNL and postoperative outcomes, including the stone-free rate (SFR) and Clavien complication grades, in both high- and low-score groups.
resultsBased on preoperative S.T.O.N.E. scores, 323 patients were classified into a high-score group (n = 110) and a low-score group (n = 213). In the high-score group, the SFR of the standard-tract (24F) PCNL (SPCNL) [72.6% (45/62)] was significantly higher than that of the mini-tract (18F) PCNL (MPCNL) [33.3% (16/48)]. The mean operative time for SPCNL [112.5 (104.5-123.0) min] was shorter than for MPCNL [134.0 (118.8-137.0) min] (P < 0.05). However, the proportion of severe complications was comparable between SPCNL [56.5% (35/62)] and MPCNL [52.1% (25/48)] (P = 0.648). In the low-score group, the SFR and operative time did not differ significantly between SPCNL [92.0% (80/87), 90.0 (70.0-118.0) min] and MPCNL [86.5% (109/126), 85.0 (64.0-109.3) min] (P > 0.05). However, SPCNL had a higher rate of severe complications [28.7% (25/87)] than MPCNL [12.7% (16/126)] (P < 0.05). Stepwise and multivariate logistic regression analyses identified the S.T.O.N.E. score (OR = 3.15, 95% CI 1.60-6.21, P < 0.001) and operative time (OR = 1.04, 95% CI 1.02-1.06, P < 0.001) as independent risk factors for stone residuals, whereas tract size (OR = 2.88, 95% CI 1.52-5.48, P = 0.001) served as an independent protective factor. The ROC curve demonstrated that the predictive model performed significantly better than any single independent factor (AUC = 0.836).
conclusionThe S.T.O.N.E. score was significantly associated with tract size selection in PCNL. Among patients with high S.T.O.N.E. scores, SPCNL yielded higher stone-free rates and shorter operative times with similar safety compared to MPCNL, supporting the use of standard tracts in this group. In low-score patients, SPCNL and MPCNL demonstrated comparable efficacy, whereas MPCNL resulted in fewer complications. Multivariable analysis identified the S.T.O.N.E. score and operative time as independent risk factors for residual stones, while larger tract size was an independent protective factor. These findings suggest that the S.T.O.N.E. score may guide personalized tract size selection in PCNL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.